Clinical Trial Update: Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial investigating combined nivolumab and trabectedin in metastatic or inoperable soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)
• nivolumab (nivolumab)

Snippet

Sponsor: University Medicine Greifswald | Conditions: Metastatic Adult Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED